Compare Infosys Limited (INFY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Infosys Limited vs Sana Biotechnology Inc — how do they compare? Infosys Limited trades at $11.18 (market cap $46.65B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Infosys Limited is far larger — about 53.4× Sana Biotechnology Inc's market cap, and Infosys Limited pays a 4.63% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| INFY | SANA | |
|---|---|---|
Market Cap | $46.65B | $873.84M |
Sector | Technology | Health |
52-Week High | $20.22 | $5.92 |
52-Week Low | $10.49 | $2.68 |
Enterprise Value | $43.87B | $848.03M |
Dividend Yield | 4.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
